Literature DB >> 30341586

Do you have restless leg syndrome? I understood from your eyes.

Hatice Kose Ozlece1, Volkan Solmaz2, Sadık Altan Özal3, Yahya Çelik4.   

Abstract

PURPOSE: According to many studies in the literature, there is a strong association between restless leg syndrome and dopaminergic dysfunction. Dopamine is also the major catecholamine in the retina and is also a possible transmitter of the amacrine and interplexiform cells. The aim of this study is to investigate the possible association between RLS and retinal thickness.
METHODS: In this study, we included 33 patients who were diagnosed with idiopathic RLS according to the "International RLS Study Group" criteria and 31 healthy subjects. All the patients and controls underwent routine ophthalmologic examination and had spectral-domain optical coherence tomography (OCT) performed. We compared the retinal thickness of the patients and control subjects.
RESULTS: In the RLS group, foveal thickness was thinner then controls. Also, only inferior, superior, and temporal quadrant retina nerve fiber layer (RNFL) thickness were significantly thinner in the RLS group. The parafoveal ganglion cell complex (GCC) in the superior temporal, inferior temporal, inferior nasal quadrant, and perifoveal superior nasal thickness was also significantly thinner in the patient group. Pearson correlation analyses showed that there were statistically significant negative correlations between disease duration and macular GCC and RNFL thickness. Negative correlations were also detected between parafoveal superior, temporal, inferior and nasal macular thickness, parafoveal superior nasal, inferior temporal GCC thickness, and perifoveal superior nasal GCC thickness and disease duration.
CONCLUSION: According to our results; most retinal layers are thinner in RLS patients, so it can be considered that OCT has a predictive value for progression of RLS.

Entities:  

Keywords:  OCT; Restless leg syndrome; Retinal thickness

Mesh:

Substances:

Year:  2018        PMID: 30341586     DOI: 10.1007/s11325-018-1740-5

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  29 in total

1.  Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex.

Authors:  W Bara-Jimenez; M Aksu; B Graham; S Sato; M Hallett
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

2.  Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.

Authors:  N Turjanski; A J Lees; D J Brooks
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

3.  Extrasynaptic release of GABA by retinal dopaminergic neurons.

Authors:  Hajime Hirasawa; Michelino Puopolo; Elio Raviola
Journal:  J Neurophysiol       Date:  2009-04-29       Impact factor: 2.714

Review 4.  Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders.

Authors:  Valerio Carelli; Chiara La Morgia; Maria Lucia Valentino; Piero Barboni; Fred N Ross-Cisneros; Alfredo A Sadun
Journal:  Biochim Biophys Acta       Date:  2009-03-05

5.  Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine.

Authors:  A L Chesson; M Wise; D Davila; S Johnson; M Littner; W M Anderson; K Hartse; J Rafecas
Journal:  Sleep       Date:  1999-11-01       Impact factor: 5.849

6.  Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss.

Authors:  Marilita M Moschos; Georgios Tagaris; Ioannis Markopoulos; Ioannis Margetis; Stylianos Tsapakis; Menelaos Kanakis; Chrysanthi Koutsandrea
Journal:  Eur J Ophthalmol       Date:  2011 Jan-Feb       Impact factor: 2.597

7.  Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome.

Authors:  Arthur S Walters; Cheryl LeBrocq; Anjana Dhar; Wayne Hening; Ray Rosen; Richard P Allen; Claudia Trenkwalder
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

8.  Retinal nerve fiber layer thinning in Parkinson disease.

Authors:  Rivka Inzelberg; Jose Antonio Ramirez; Puiu Nisipeanu; Avinoam Ophir
Journal:  Vision Res       Date:  2004-11       Impact factor: 1.886

9.  Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.

Authors:  James R Connor; Xin-Sheng Wang; Richard P Allen; John L Beard; Jason A Wiesinger; Barbara T Felt; Christopher J Earley
Journal:  Brain       Date:  2009-05-25       Impact factor: 13.501

10.  The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease.

Authors:  G F Yavas; O Yilmaz; T Küsbeci; F Oztürk
Journal:  Eur J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 2.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.